A new clinical study has found that a wearable device developed by PD Neurotechnology was 95% accurate in detecting and assessing motor symptoms of Parkinson’s disease, wh
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh